Introduction: Action bitters, commonly used in traditional medicine, have an unclear safety profile and potential effects on lung, liver, and kidney tissues. This experimental study investigated the histological effects of action bitters on the lungs, liver, and kidney tissues of adult male Wistar rats. Understanding these effects is crucial, as it can provide insights into the safety and potential risks associated with the use of action bitters in traditional medicine.

Methodology: A total of 18 adult male rats were used in this study. The rats were divided into three groups, each consisting of six rats (n = 6). Group A served as the normal control group, receiving no action bitters. Group B was administered 10% of the lethal dose 50 (LD50) of action bitters, equivalent to 0.66 ml/kg. Group C received 5% of the LD50, equivalent to 0.33 ml/kg. The administration of action bitters continued for 28 days. After this period, lung and kidney tissues were harvested and examined using hematoxylin and eosin staining.

Results: The results of the study showed no significant histological changes or inflammation in the lung and kidney tissues of all groups. This indicates that, under the conditions of this experiment, the administration of action bitters did not cause observable damage or alterations in the histology of these organs. However, it is important to note that these findings are specific to the conditions and dosages used in this study, and further research is needed to confirm these results across different conditions and dosages.

Conclusion: The study suggests that action bitters may have a limited impact on the histology and function of the lungs, liver, and kidneys. These findings contribute to our understanding of the safety profile of action bitters, indicating that, at least at the tested doses, they do not cause significant histological damage to these organs. However, the study also highlights the need for further research to fully define the effects of action bitters on lung, liver, and kidney tissues.

Histological Effects, Chronic Consumption, Action Bitters

Adewole, S. O., Ojewole, J. A., & Olaleye, S. B. (2016). Toxicological evaluation of Action Bitters in rats. Journal of Ethnopharmacology, 193, 835-844.

Aladejana, E. B. (2023). Biological Properties of Polyherbal Formulations: A Review of their Antimicrobial, Anti-Inflammatory, Antioxidant, and Toxicological Activities. Pharmacognosy Journal, 15(5), 933-963.

Albertine, K. H., & Wang, X. (2018). Lung structure and function. Journal of Comprehensive Physiology, 8(2), 621-646.

Anayasor HG, Ogunbiyi Akinlisi AI. (2017). Antioxidant and anti-inflammatory properties of selected polyherbal preparations: Oroki herbal; Sweddish bitters and Yoyo bitters. Oxidants and Anti-oxidant in Medical Sciences, 6(2), 25-29.

Anionye JC, Onyeneke EC. (2016) Composition and invitro antioxidant capacity of Alomo bitters. European Journal of Biological Sciences, 8(3), 116-123.

Ayustaningwarno, F., et al. (2024). A critical review of Ginger’s (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities. Frontiers in Nutrition, 11, 1364836.

Baydoun S, Chalak L, Dalleh H, Arnold N. (2015) Ethnopharmacological survey of medicinal plants used in traditional medicine by the communities of Mount Hermon, Lebanon. J Ethnopharmacol. 2015 Sep 15;173:139-56. doi: 10.1016/j.jep.2015.06.052. Epub 2015 Jul 9. PMID: 26165826.

Carissa Stephens (2019). The ultimate guide to bitters. Available at: https://www.healthline.com/health/food-nutrition/how-to-use-bitters. (Accessed: 23 April 2024).

Chen, T., et al. (2024). Recent advances in the potential effects of natural products from traditional Chinese medicine against respiratory diseases targeting ferroptosis. Chinese Medicine, 19, 49.

Crapo, J. D., Glassberg, M. K., & Leslie, K. O. (2017). Pathology of lung disease. Pathology: A Modern Approach (pp. 437-464).

Ehebha, S.E., Ogwu, S.C., Obohwemu, K.O. and Egbowawa, P.U., 2024. HISTOLOGICAL EVALUATION OF THE EFFECTS OF ACTION BITTERS ON THE TESTES OF ADULT MALE WISTAR RATS. The American Journal of Interdisciplinary Innovations and Research, 6(11), pp.194-203.

Esimone, C. O., et al. (2011). Evaluation of the anti-inflammatory activity of Action Bitters. Journal of Ethnopharmacology, 137(1), 396-401.

Gruenwald, J., Brendler, T., & Jaenicke, C. (2010). PDR for herbal medicines. Thomson Reuters.

Hall, J. E. (2015). Guyton and Hall textbook of medical physiology (13th ed.). W B Saunders.

Helen A. Waribo, Esther Edamisan, Ibioku Elekima and Ebirien-Agana S. Bartimaeus. (2021). Effect of oral consumption of Action bitters on renal indices of apparently healthy subjects in Port Harcourt metropolis. Asian Journal of Biochemistry, Genetics and Molecular Biology, 9(3): 14-19.

Hoffmann D. (2002). Holistic Herbal. A safe and practical Guide to Making and Using Herbal remedies. (1st Edition). Harper Collins Publishers, Australia.

Hong, M., et al. (2015). Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects. International Journal of Molecular Sciences, 16(12), 28705-28745.

Igoli, J. O., et al. (2005). Evaluation of the expectorant activity of Action Bitters. Journal of Pharmacy and Pharmacology, 57(11), 1423-1428.

Kim, S., Cho, Y., Kim, H., & Kang, S. (2019). Herbal medicines for treating metabolic syndrome: A systematic review of animal studies. Evidence-Based Complementary and Alternative Medicine, 2019, 1-15.

McDonald J. (2014). A potent herbal drug in the treatment of kidney and liver disease. Blessed Bitters.

Mohammed SA Suresh M. (2020). Antifungal efficacy and mechanism of flavonoids. Antibiotics, 9(2), 45-47.

Nwodo, O. F., & Aligbe, J. U. (2017). Phytochemical analysis and antimicrobial activity of Action Bitters. Journal of Medicinal Plants Research, 11(15), 289-297.

Oforibika GA, Oforibika DA. (2020). Toxicological effects of overdose of some herbal bitters commonly consumed in South Southern Nigeria. Asian Journal of Medical Principlse and Clinical Practice, 3(2): 35-39.

Olaleye, S. B., & Adewole, S. O. (2013). Hepatotoxicity and nephrotoxicity of Action Bitters in rats. Journal of Environmental Science, Toxicology and Food Technology, 3(2), 38-44.

Oyagbemi, A. A., & Odetola, A. A. (2015). Herbal medicine and lung disease. Journal of Ethnopharmacology, 159, 267-275.

Oyedemi, S. O., et al. (2012). Antioxidant and free radical scavenging activities of Action Bitters. Journal of Medicinal Food, 15(10), 931-938.

Qing L, Xiao M, Ya L, Cai-Ning Z, Guo-Y, Hua_Bin T. (2017). Antibacterial and antifungal activities of spices. International. Journal of Molecular Sciences, 18(6), 1283-1285.

Robinson, D. (2019). Animal Models in Toxicology Research. Springer: New York.

Tahi, A., Benkiki, N., & Zrara, I. (2020). Ethnopharmacological survey of medicinal plants used in traditional medicine in Morocco. Journal of Ethnopharmacology, 247, 112348.

Tsibulsky, W. L., & Amit, Z. (1993). Tolerance to effects of high doses of ethanol: 1. Lethal effects in mice. Pharmacology Biochemistry and Behavior, 45(2), 465-472.